Skip to content

Member News Update from Lab Data Solutions LLC

Date: March 14, 2026

This news piece has been submitted by Lab Data Solutions LLC

We’re Attending US Summit 2026!

Lab Data Solutions LLC is pleased to announce that we will be attending the ACDM US Summit 2026, taking place May 18–19, 2026, in Princeton, New Jersey. Hosted by Genmab, this inaugural Summit marks an important milestone for the clinical data management community—and for us, it represents our first public appearance as a company.

The ACDM US Summit brings together leading voices in Clinical Data Management and the broader clinical research ecosystem to advance discussion, collaboration, and shared learning. Designed as a forum for both scientific and practical exchange, the Summit focuses on strengthening how data management supports trust, innovation, and impact across clinical research.

Under the theme “Clinical Data Management at the Heart: Driving Trust, Innovation, and Impact,” the programme includes thought‑leadership sessions, real‑world case discussions, and meaningful networking opportunities. The event will begin with a networking evening on May 18, followed by a full day of focused sessions and discussions on May 19.

As a company dedicated to supporting high‑quality lab data and reliable data review processes, Lab Data Solutions LLC values opportunities to engage directly with peers, sponsors, CROs, and data professionals who share a commitment to data integrity and operational excellence. The Summit’s emphasis on collaboration and inclusivity—welcoming participants from across the global ACDM community—aligns closely with our own approach to clinical data work.

We look forward to learning from industry leaders, contributing to conversations shaping the future of clinical data management, and building connections within the clinical research community. If you will be attending the ACDM US Summit 2026, we would welcome the opportunity to connect and exchange perspectives.

 


 

Explore More News

Welcome IROS – Insights Research Organization & Solutions as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome IROS – Insights . . .

Read More

Recommendation paper on decentralised elements in clinical trials

Following their meeting on 4 Oct, the EMA/HTAs and EC have published a recommendation . . .

Read More

Welcome George Clinical as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome George Clinical . . .

Read More

Welcome Clinion as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Clinion as a . . .

Read More

Welcome ClinoSol Research as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome ClinoSol . . .

Read More

CTU DMEG Update

The CTU DMEG has been actively discussing common problems that data managers face in . . .

Read More

ICH E8 (R1) General Considerations for Clinical Studies Impact on Data Management

The ACDM Regulatory Considerations have reviewed the Revision 1 to the ICH E8 Guidelines . . .

Read More

ACDM Comments on “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations; Draft Guidance for Industry, Investigators, and Other Stakeholders; Availability”

https://acdmglobal.org/wp-content/uploads/2022/04/ACDM_FDA_DHT.pdf

Read More

Have your say – MHRA’s public consultation on proposals for legislative changes for clinical trials

Dear Colleague, We have just launched our 8-week public consultation on proposals for . . .

Read More

Signant Health are ACDM22 Photography sponsors

The Association for Clinical Data Management are delighted to announce that Signant Health . . .

Read More

Anju Software is exhibiting at ACDM22

The Association for Clinical Data Management is delighted to announce that Anju Software . . .

Read More

SGS Health Science to sponsor ACDM Awards for the second year running

The Association for Clinical Data Management are delighted to announce that SGS Health . . .

Read More